Soleno Therapeutics Inc

SLNODelisted May 18, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001484565

SEC filings (opens in a new tab)

Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.

Q2 2024 vs. Q1 2024

How the institutions holding Soleno Therapeutics Inc changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of SLNO: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	98	2	114	+18
Shares	35.5M	19.1K	43.9M	+8.35M (+23.5%)
Value	$1.52B	$814.0K	$1.79B	+$271.3M (+17.9%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held Soleno Therapeutics Inc at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to SLNO in Q2 2024
Institution	Shares	Value	% of portfolio
Assenagon Asset Management S.A.	729,841	$29.8M	0.07%
Holocene Advisors, LP	536,451	$21.9M	0.09%
Driehaus Capital Management LLC	145,110	$5.92M	0.06%
Bank of New York Mellon Corp	88,799	$3.62M	0.00%
Polar Asset Management Partners Inc.	74,500	$3.04M	0.08%
Nuveen Asset Management, LLC	59,478	$2.43M	0.00%
Norges Bank	57,770	$2.36M	0.00%
ADAR1 Capital Management, LLC	39,929	$1.63M	0.33%
Hudson Bay Capital Management LP	30,000	$1.22M	0.01%
Rhumbline Advisers	29,144	$1.19M	0.00%
J. Goldman & Co LP	26,938	$1.10M	0.04%
Alliancebernstein L.P.	24,610	$1.00M	0.00%
Alpine Global Management, LLC	20,824	$849.6K	0.15%
Checkpoint Capital L.P.	19,695	$803.6K	0.48%
UBS Oconnor LLC	15,000	$612.0K	0.02%
Silverarc Capital Management, LLC	15,000	$612.0K	0.15%
SG Americas Securities, LLC	13,941	$569.0K	0.00%
Cinctive Capital Management LP	13,190	$538.2K	0.03%
NEOS Investment Management LLC	12,950	$528.4K	0.02%
Corebridge Financial, Inc.	11,832	$482.9K	0.00%
Deutsche Bank AG	9,469	$386.3K	0.00%
Citadel Advisors LLC	8,127	$331.6K	0.00%
Voya Investment Management LLC	7,364	$300.5K	0.00%
State Board of Administration of Florida Retirement System	6,630	$270.5K	0.00%
Omers Administration Corp	6,200	$253.0K	0.00%
MetLife Investment Management	5,576	$227.5K	0.00%
Ameritas Investment Partners, Inc.	2,155	$87.9K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	2,031	$84.8K	0.00%
Aquatic Capital Management LLC	900	$36.7K	0.00%
Amalgamated Bank	761	$31.0K	0.00%
FMR LLC	11	$449	0.00%
Allworth Financial LP	5	$235	0.00%
Rothschild Investment LLC	5	$204	0.00%
Quantbot Technologies LP	4	$163	0.00%
CWM, LLC	2	$0	0.00%

Sold out (17)

Institutions that held Soleno Therapeutics Inc at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of SLNO in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Marshall Wace, LLP	176,237	$7.54M
StemPoint Capital LP	115,833	$4.96M
EAM Investors, LLC	64,411	$2.76M
Farallon Capital Management, L.L.C.	27,750	$1.19M
Allianz Asset Management GmbH	25,100	$1.07M
Squarepoint Ops LLC	14,580	$624.0K
ExodusPoint Capital Management, LP	14,206	$608.0K
Cannon Global Investment Management, LLC	11,800	$505.0K
HighVista Strategies LLC	10,428	$446.3K
Polymer Capital Management (HK) LTD	6,914	$295.9K
LMR Partners LLP	6,830	$292.3K
AQR Capital Management LLC	6,792	$290.7K
E Fund Management Co., Ltd.	5,016	$214.7K
Quarry LP	1,650	$70.6K
EntryPoint Capital, LLC	135	$5.78K
Harbour Investments, Inc.	5	$214
Macquarie Group Ltd	1,736	$74

Not filed for Q2 2024 yet (2)

Institutions that held Soleno Therapeutics Inc at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SLNO in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	17,219	$737.0K
Shell Asset Management Co	1,881	$77.0K